Home Cart Sign in  
Chemical Structure| 2169919-21-3 Chemical Structure| 2169919-21-3

Structure of Revumenib
CAS No.: 2169919-21-3

Chemical Structure| 2169919-21-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Revumenib (SNDX-5613) is an effective and specific Menin-MLL inhibitor with a binding Ki of 0.149 nM. In cellular experiments, it inhibits Menin-MLL with an IC50 of 10-20 nM. Revumenib can be utilized in research on acute leukemia with MLL gene rearrangements, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

Synonyms: SNDX-5613

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Revumenib

CAS No. :2169919-21-3
Formula : C32H47FN6O4S
M.W : 630.82
SMILES Code : C(N1CCC2(CN(C2)C=3C(OC4=C(C(N(C(C)C)CC)=O)C=C(F)C=C4)=CN=CN3)CC1)[C@@H]5CC[C@@H](NS(CC)(=O)=O)CC5
Synonyms :
SNDX-5613
MDL No. :MFCD32701940

Safety of Revumenib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Revumenib

epigenetics

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05918913 Relapsed/Refractory Acute Leuk... More >>emia Less << AVAILABLE - Alabama Center for Childhood C... More >>ancer And Blood Disorders, Children's of Alabama, Birmingham, Alabama, 35233, United States|Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|City of Hope, Duarte, California, 91010, United States|City of Hope at Orange County Lennar Foundation Cancer Center, Irvine, California, 92618, United States|UCLA, UCLA RRMC, Drug Information Center, Department of Pharmaceutical Services Drug Supply Shipment, Los Angeles, California, 90095, United States|Lucile Packard Children's Hospital-Stanford, Palo Alto, California, 94304, United States|Rady Children's Hospital, San Diego, California, 92123, United States|University of California, San Francisco, San Francisco, California, 94158, United States|Center for Cancer and Blood Disorders, Colorado Children's Hospital, Aurora, Colorado, 80045, United States|HCTU, Division of Hematology, University of Colorado, Anschutz Medical Center, Aurora, Colorado, 80045, United States|Advent Health Orlando, Orlando, Florida, 32804, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Winship Cancer Institute at Emory University, Atlanta, Georgia, 30322, United States|Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Children's Hospital, New Orleans, Louisiana, 70118, United States|Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, 02215, United States|Children's Mercy Hospital-Kansas City, Kansas City, Missouri, 64108, United States|Siteman Cancer Center - Washington University, Saint Louis, Missouri, 63110, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|Memorial Sloan Kettering Cancer Center, Long Island City, New York, 10065, United States|Duke University Medical Center, Durham, North Carolina, 27705, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Division of Hematology and Oncology, Division of Pulmonary, Critical Care and Sleep Medicine, Vontz Center for Molecular Studies, Cincinnati, Ohio, 45267, United States|OSU Medical Center, Columbus, Ohio, 43210, United States|Doernbecher Children's Hospital, Oregon Health & Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Memorial Hermann-Texas Medical Center, Houston, Texas, 77030, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital, Salt Lake City, Utah, 84112, United States|Seattle Children's Research Institute, Seattle Childrens Hospital, Seattle, Washington, 98105, United States Less <<
NCT06229912 Leukemia|HOX Gene PHASE2 RECRUITING 2028-12-01 MD Anderson Cancer Center, Hou... More >>ston, Texas, 77030, United States Less <<
NCT05406817 Acute Leukemia PHASE1 COMPLETED 2024-11-18 MD Anderson Cancer Center, Hou... More >>ston, Texas, 77030, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.59mL

0.32mL

0.16mL

7.93mL

1.59mL

0.79mL

15.85mL

3.17mL

1.59mL

 

Historical Records

Categories